Lataa...
Identification of Positive Allosteric Modulators of the D(1) Dopamine Receptor That Act at Diverse Binding Sites
The D(1) dopamine receptor is linked to a variety of neuropsychiatric disorders and represents an attractive drug target for the enhancement of cognition in schizophrenia, Alzheimer disease, and other disorders. Positive allosteric modulators (PAMs), with their potential for greater selectivity and...
Tallennettuna:
| Julkaisussa: | Mol Pharmacol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6117505/ https://ncbi.nlm.nih.gov/pubmed/30068735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.118.113175 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|